CIPO trademark

BYLTIMRIZ

FiledCIPOWord markClass 5

"BYLTIMRIZ" is a word mark owned by ABIVAX, Société de droit français, filed at the CIPO on October 9, 2026. It is filed and waiting for examination and covers class 5 (Pharmaceuticals).

Get this data via the API
Official CIPO record
BYLTIMRIZ
Word mark as filed with the CIPO
Status
Filed
Since October 9, 2026
Filed
October 9, 2026
Registered
Not yet
Priority date
October 8, 2026
Claimed from France
Application no.
2506782
Registration no.
Not yet
Office
CIPO
Canadian Intellectual Property Office
Mark type
Word mark
1 class
Ownership

Who owns BYLTIMRIZ

The owner and representative on file with the office.

Owner

ABIVAX, Société de droit français

France

Representative

Robic Agence Pi S.E.C./ Robic IP Agency LP

Robic Agence Pi S.E.C./ Robic IP Agency LP

Goods and services

What the mark covers

The products and services BYLTIMRIZ is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of inflammatory diseases, immune-mediated and autoimmune diseases, disorders and conditions affecting the gastrointestinal tract, namely, inflammation associated with colon carcinoma, pouchitis, Inflammatory Bowel Disease, including Crohn's disease and Ulcerative Colitis, checkpoint inhibitor colitis and eosinophilic esophagitis; Chemical preparations for medical purposes for the treatment of inflammatory diseases, immune-mediated and autoimmune diseases, disorders and conditions affecting the gastrointestinal tract, namely, inflammation associated with colon carcinoma, pouchitis, Inflammatory Bowel Disease, including Crohn's disease and Ulcerative Colitis, checkpoint inhibitor colitis and eosinophilic esophagitis; Chemical preparations for pharmaceutical purposes for the treatment of inflammatory diseases, immune-mediated and autoimmune diseases, disorders and conditions affecting the gastrointestinal tract,namely, inflammation associated with colon carcinoma, pouchitis, Inflammatory Bowel Disease, including Crohn's disease and Ulcerative Colitis, checkpoint inhibitor colitis and eosinophilic esophagitis.

History

What has happened so far

Steps recorded by the CIPO, newest first.

  1. Formalized
  2. Created
  3. Filed
FAQ

About BYLTIMRIZ

Who owns the trademark "BYLTIMRIZ"?

The CIPO trademark "BYLTIMRIZ" (application 2506782) is owned by ABIVAX, Société de droit français.

What is the status of "BYLTIMRIZ"?

Its status at the CIPO is: filed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull BYLTIMRIZ and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a13b99-184c-7482-bf60-8a132b439b7b
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a13b99-184c-7482-bf60-8a132b439b7b",
  "object": "trademark",
  "mark_text": "BYLTIMRIZ",
  "status": {
    "primary": "pending",
    "stage": "filed"
  },
  "office_code": "CA",
  "application_number": "2506782",
  "filing_date": "2026-10-09",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "ABIVAX, Société de droit français",
      "entity_id": null
    }
  ]
}